The Food and Drug Administration (FDA) conducted an inspection at Endometriosis & Reproductive Surgery Specialists, P.L.L.C. in Scottsdale on April 21, reviewing the facility’s practices related to human cellular, tissue, and gene therapies, according to data posted on the FDA’s website.
The concluding report stated that Endometriosis & Reproductive Surgery Specialists, P.L.L.C. was not required to make any changes to its operational management.
The FDA regularly inspects facilities nationwide to assess whether workplaces and their products adhere to FDA regulations designed to enhance public health. Inspection outcomes are released publicly.
According to its website, the FDA is a federal agency responsible for overseeing the safety and quality of human and animal drugs, biological products, medical supplies, and tobacco products.
Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.
